Heather A. Berger

Insider Reports History

Location
Waltham, MA
Signature
/s/ Mustapha Parekh, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Heather A. Berger:

Company Role Class Num Shares Value Price $ Report Date Ownership
Design Therapeutics, Inc. Director Stock Option (right to buy) 19,000 10 Jun 2025 Direct
Entasis Therapeutics Holdings Inc. Director Common Stock 0 $2.20 11 Jul 2022 Direct
Entasis Therapeutics Holdings Inc. Director Stock Option (right to buy) 0 11 Jul 2022 Direct

Insider Reports Filed by Heather A. Berger

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DSGN Design Therapeutics, Inc. 10 Jun 2025 1 $0 4 Director 12 Jun 2025, 16:30
DSGN Design Therapeutics, Inc. 13 Jun 2024 1 $0 4 Director 17 Jun 2024, 17:00
DSGN Design Therapeutics, Inc. 25 Mar 2024 1 +$4,866 4 Director 25 Mar 2024, 19:09
DSGN Design Therapeutics, Inc. 31 May 2023 1 $0 4 Director 02 Jun 2023, 16:31
/report/000110465922078788-berger-heather-a-2022-07-07 Entasis Therapeutics Holdings Inc. 07 Jul 2022 4 -$108,900 4 Director 11 Jul 2022, 16:04
DSGN Design Therapeutics, Inc. 15 Jun 2022 1 $0 4 Director 16 Jun 2022, 17:05
/report/000110465922005418-behanna-heather-2022-01-18 Entasis Therapeutics Holdings Inc. 18 Jan 2022 1 $0 4 Director 19 Jan 2022, 15:02
/report/000110465922023772-behanna-heather-2021-07-16 Entasis Therapeutics Holdings Inc. 16 Jul 2021 4 $0 4 Director 15 Feb 2022, 15:02
DSGN Design Therapeutics, Inc. 15 Jun 2021 1 $0 4 Director 16 Jun 2021, 17:17
DSGN Design Therapeutics, Inc. 15 Jun 2021 0 $0 3 Director 16 Jun 2021, 17:15